Medical Marijuana for those with Glaucoma
Hepatitis C has negatively impacted millions of lives, and medical researchers have tried for decades to develop a vaccine with no luck. But today, our team at the Wyoming Institute of Technology is pleased to announce that, with the help of our pharmaceutical partners, we’ve cracked the code and can deliver a cost-effective vaccine and cure to the world within the next 14 to 18 months… and we owe it all to cannabis. Our research into the field of hepatitis C vaccination began last fall, after one of our interns had alleged that she had completely “cured” herself of hepatitis C by edifying and vaporizing a strain of cannabis that she herself had invented, which she calls “Chunky Crimson.”
In May, the WIT team, working closely with a medical marijuana dispensary in Denver and also with a team from GlaxoSmithKline, developed a trial medication based on “Chunky Crimson” which is consumed three times daily, and coupled with a suppository admitted once daily. Human trials showed that 99.8% of recipients of the test drug were fully cured of Hepatitis C, while the remaining 0.2% showed signs of reversal, and could theoretically be cured with continued administering of the rectal suppository alone.
* as always please be sure to consult with a health professional to assess the risks and rewards of adding medicinal cannabis to your treatment program.